Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 5/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.97 |
| ▸ | HTT | P42858 | 1/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromhexine SCHEMBL19059 | 1.00 | CYP2D6 (1.00) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| Bromhexine SCHEMBL10704011 | 0.99 | LMNA (1.00) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| Bromhexine SCHEMBL18548828 | 0.99 | CYP2D6 (0.97) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| Bromhexine SCHEMBL99613 | 0.99 | LMNA (1.00) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| Bromhexine SCHEMBL5968149 | 0.90 | CYP2D6 (0.81) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| Bromhexine SCHEMBL8573766 | 0.90 | CYP2D6 (0.81) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| SCHEMBL13907693 | 0.88 | CYP2D6 (0.79) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| SCHEMBL11617745 | 0.87 | CYP2D6 (0.77) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| SCHEMBL11622934 | 0.87 | CYP2D6 (0.77) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 | |
| SCHEMBL23318472 | 0.86 | CYP2D6 (0.75) | CYP2D6SLC6A4KCNH2ABCB11ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3793520-B1 | AN ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE THROAT COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-04-30 | — | — | EP | claimed |
| EP-3793518-B1 | AN ORAL TABLET FOR TASTE MASKING OF ACTIVE INGREDIENTS COMPRISING NON-DIRECTLY COMPRESSIBLE SUGAR ALCOHOL PARTICLES | FERTIN PHARMA AS (DK) | 2025-03-26 | — | — | EP | claimed |
| EP-4088716-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2024-10-16 | — | — | EP | claimed |
| EP-4308103-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | AI Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3638223-B1 | BROMHEXINE FOR THE TREATMENT OF PAIN | KERN KAI UWE (DE) | 2023-10-25 | — | — | EP | claimed |
| WO-2022197667-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | YOUNG PETER R (US) | 2022-09-22 | — | — | WO | claimed |
| EP-3003285-B1 | SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST TWO ACTIVE PHARMACEUTICAL INGREDIENTS IN THE ORAL CAVITY | MCNEIL AB (SE) | 2022-02-16 | — | — | EP | claimed |
| US-20260144746-A1 | Protein Based Soft Chew Tablets | FERTIN PHARMA A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| US-20260144745-A1 | Sugar Free Soft Chew Tablets | FERTIN PHARMA A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| EP-4734952-A1 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | Fertin Pharma A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| EP-3932389-B1 | COMPOSITION FOR THE TREATMENT AND PREVENTION OF AT LEAST ONE SYMPTOM OF A SECONDARY DISEASE ASSOCIATED WITH COVID-19 IN HUMANS | SCHMIDT WERNER (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-12551439-B2 | Flowpack for oral delivery of active ingredients | FERTIN PHARMA A/S (DK) | 2026-02-17 | — | — | US | disclosed |
| US-11351162-B2 | Oral delivery vehicle containing flavoring agents | FERTIN PHARMA A/S (DK) | 2022-06-07 | — | — | US | disclosed |
| WO-2022092284-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | 日産化学株式会社 | 2022-05-05 | — | — | WO | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-11260030-B2 | Oral tablet for delivery of active ingredients to the gastrointestinal tract | FERTIN PHARMA A/S (DK) | 2022-03-01 | — | — | US | disclosed |
| EP-3003285-B1 | SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST TWO ACTIVE PHARMACEUTICAL INGREDIENTS IN THE ORAL CAVITY | MCNEIL AB (SE) | 2022-02-16 | — | — | EP | disclosed |
| EP-3947434-A2 | ENGINEERED PLATELETS FOR TARGETED DELIVERY OF A THERAPEUTIC AGENT | JPV01 Ltd (GB) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144745-A1 | Sugar Free Soft Chew Tablets | SI, TREH, SLC2A3 | CYP2D6 954/4885SLC6A4 304/4885KCNH2 1243/4885 |
| US-12551439-B2 | Flowpack for oral delivery of active ingredients | GCK, SLC2A8, SLC2A1 | CYP2D6 959/4885SLC6A4 332/4885KCNH2 4233/4885 |
| US-20260144746-A1 | Protein Based Soft Chew Tablets | CARHSP1, HIRA, HEATR6 | CYP2D6 4072/4885SLC6A4 2003/4885KCNH2 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.